Summa Four definition

Summa Four means Cisco, (ii) to "Common Stock" or "Common Shares" shall mean shares of Cisco Stock, (iii) to the "Board of Directors" or the "Board" shall mean the Board of Directors of Cisco and (iv) to the "Committee" shall mean the Compensation Committee of the Cisco Board of Directors.
View Source
Summa Four is entitled to enforce the provisions of this Agreement by any means allowed by law including seeking to obtain injunctive relief and/or specific performance.
View Source

Examples of Summa Four in a sentence

  • LLC was formed as of the date hereof pursuant to an Operating Agreement executed by Summa Four and Junction, Inc.

  • TeleScript is a fourth generation language designed to command the Summa Four SDS family of switches to perform complex callflows and resource management.

  • Upon any such termination, Contractor shall promptly deliver to Summa Four any and all Work Product (including but not limited to any other materials, products, supplies and/or Confidential Information of or to be returned to Summa Four hereunder) completed as of the date of such termination.

  • Furthermore, Contractor is solely responsible for and shall indemnify Summa Four against all liability, claim, expense and/or cost in connection with its performance under this agreement including but not limited to the payment of all federal, state and local taxes or contributions which may be imposed on Contractor or Summa Four including unemployment insurance, social security and income tax levies associated with Contractor's performance under this Agreement.

  • Hardware may include, but is not limited to: host computers, Summa Four switches, modems, cables and wiring.

  • Contractor may not assign its obligations or responsibilities under this Agreement without the written consent of Summa Four.

  • Trilogy hereby grants to Customer a ---------------------- nonexclusive, license to use TeleScript, TeleDesq 2.0 Primecall and Web-Call, as defined in Exhibit 1 of the Agreement for One (1) Summa Four Switch (collectively, the "Trilogy Software") in Customers business in any manner in Customer's sole discretion, for the term of this agreement or until termination hereof.

  • Summa Four shall compensate Contractor in accordance with the provisions of Appendix A.

  • Primecall wishes to lease with option to buy, Trilogy's proprietary software, TeleScript, to operate Primecall's Summa Four SDS 1000 installation and TeleDesq 2.0 Primecall, to manage Primecall's data entry, customer service and billing requirements through March 31, 1999.

  • Summa Four has on November 4, 1998 been acquired by Cisco through the merger of Agemo Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of Cisco, with and into Summa Four (the "Merger") pursuant to the Agreement and Plan of Reorganization dated July 27, 1998, by and among Cisco, Agemo Acquisition Corporation and Summa Four (the "Merger Agreement").

Related to Summa Four

  • Fellowship means a fellowship in a professional medical college recognized by the Board after consultation with the Medical Advisory Committee.

  • Fellow means a fellow member of the Institute;

  • Non-Participating Certified Nurse-Midwife means a Certified Nurse-Midwife who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Stage-Four Advanced, Metastatic Cancer means a cancer that has spread from the primary or original site of the cancer to nearby tissues, lymph nodes, or other areas or parts of the body.

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.